A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ARV-471|DRUG: Anastrozole|PROCEDURE: Surgical resection of breast tumor
Sponsor: Arvinas Inc.
Collaborators: Pfizer